Rocket Pharmaceuticals (RCKT)
(Delayed Data from NSDQ)
$23.38 USD
+0.29 (1.26%)
Updated May 14, 2024 04:00 PM ET
After-Market: $23.39 +0.01 (0.04%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/8/24 |
---|---|
Current Quarter | -0.74 |
EPS Last Quarter | -0.66 |
Last EPS Surprise | 4.35% |
ABR | 1.21 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.85 |
Next Year | -1.87 |
EPS (TTM) | -2.87 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | 13.86M | 26.04M | 191.59M |
# of Estimates | NA | 2 | 5 | 5 |
High Estimate | NA | 24.23M | 99.40M | 325.80M |
Low Estimate | NA | 3.48M | 0.80M | 23.10M |
Year ago Sales | 0.00M | 0.00M | NA | 26.04M |
Year over Year Growth Est. | NA | NA | NA | 635.86% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.74 | -0.68 | -2.85 | -1.87 |
# of Estimates | 6 | 5 | 8 | 6 |
Most Recent Consensus | -0.69 | -0.43 | -1.69 | -0.54 |
High Estimate | -0.65 | -0.43 | -1.69 | -0.54 |
Low Estimate | -0.82 | -0.87 | -3.31 | -3.02 |
Year ago EPS | -0.82 | -0.75 | -2.92 | -2.85 |
Year over Year Growth Est. | 9.76% | 9.33% | 2.40% | 34.20% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 2 | 3 | 4 | 2 |
Up Last 30 Days | 3 | 5 | 6 | 3 |
Up Last 60 Days | 3 | 5 | 6 | 3 |
Down Last 7 Days | 1 | 0 | 0 | 2 |
Down Last 30 Days | 2 | 0 | 0 | 3 |
Down Last 60 Days | 2 | 0 | 0 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.74 | -0.68 | -2.85 | -1.87 |
7 Days Ago | -0.69 | -0.70 | -2.93 | -1.91 |
30 Days Ago | -0.69 | -0.71 | -2.94 | -1.91 |
60 Days Ago | -0.69 | -0.71 | -2.94 | -1.91 |
90 Days Ago | -0.71 | -0.72 | -3.04 | -1.75 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.74 | -0.68 | -2.70 | -1.87 |
Zacks Consensus Estimate | -0.74 | -0.68 | -2.85 | -1.87 |
Earnings ESP | 0.00% | 0.00% | 5.14% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.66 | -0.64 | -0.75 | -0.82 | NA |
Estimate | -0.69 | -0.80 | -0.82 | -0.80 | NA |
Difference | 0.03 | 0.16 | 0.07 | -0.02 | 0.06 |
Surprise | 4.35% | 20.00% | 8.54% | -2.50% | 7.60% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more